- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/42 - Oxygen atoms attached in position 3 or 5
Patent holdings for IPC class C07D 211/42
Total number of patents in this class: 155
10-year publication summary
|
13
|
13
|
10
|
10
|
12
|
11
|
17
|
6
|
9
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Prilenia Neurotherapeutics Ltd. | 99 |
6 |
| Gen1e Lifesciences Inc. | 31 |
6 |
| Genentech, Inc. | 4099 |
5 |
| Xenon Pharmaceuticals Inc. | 196 |
5 |
| Janssen Pharmaceutica N.V. | 3171 |
4 |
| Massachusetts Institute of Technology | 10239 |
4 |
| Eli Lilly and Company | 4089 |
4 |
| Theravance Biopharma R&D IP, LLC | 407 |
4 |
| Bristol-myers Squibb Company | 4729 |
3 |
| Bayer Pharma AG | 1014 |
3 |
| The Broad Institute, Inc. | 1975 |
3 |
| Oregon Health & Science University | 755 |
3 |
| Chengda Pharmaceuticals Co., Ltd. | 12 |
3 |
| F. Hoffmann-La Roche AG | 7836 |
2 |
| Bayer Cropscience AG | 1846 |
2 |
| FUJIFILM Corporation | 30512 |
2 |
| ABA Chemicals Corporation | 24 |
2 |
| Amicus Therapeutics, Inc. | 354 |
2 |
| Chiesi Farmaceutici S.p.A. | 959 |
2 |
| Council of Scientific & Industrial Research | 1445 |
2 |
| Other owners | 88 |